• 介紹：

  (2-Hydroxypropyl)-β-cyclodextrin是廣泛使用的藥物遞送載體，可提高穩(wěn)定性和利用度。

• 熔點(diǎn)： 278℃ (d℃.)

• 外觀： 白色粉末

• 溶解性： DMSO  :  50  mg/mL  (Need  ultrasonic)
  
  H2O  :  50  mg/mL  (Need  ultrasonic)

• 儲存條件： RT

• 注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

• 57. [IF=6.1] Lin Zhu et al."Preparation and characterization of tea tree essential oil microcapsule-coated packaging paper with bacteriostatic effect."Food Chemistry-X".2024 Oct;23:101510

• 56. [IF=5.9] Jialing Huang et al."Development of a Syzygium aromaticum, L. essential oil/hydroxypropyl-β-cyclodextrin inclusion complex: Preparation, characterization, and evaluation."INDUSTRIAL CROPS AND PRODUCTS".2024 Aug;214:118500

• 55. [IF=10.2] Shen Huan et al."Asiatic acid cyclodextrin inclusion micro-cocrystal for insoluble drug delivery and acute lung injury therapy enhancement."JOURNAL OF NANOBIOTECHNOLOGY".2024 Dec;22(1):1-13

• 54. [IF=7.3] Jianbei Xi et al."Discovery of a First-in-Class GPR183 Antagonist for the Potential Treatment of Rheumatoid Arthritis."JOURNAL OF MEDICINAL CHEMISTRY.2023;66(23):15926–15943

• 53. [IF=7.3] Yue Li et al."Discovery of a First-in-Class CD38 Inhibitor for the Treatment of Mitochondrial Myopathy."JOURNAL OF MEDICINAL CHEMISTRY.10.1021/acs.jmedchem.3c00391

• 52. [IF=0] Zhao Yun-Qiu et al."Unravelling and engineering an operon involved in the side-chain degradation of sterols in Mycolicibacterium neoaurum for the production of steroid synthons."Biotechnology for Biofuels and Bioproducts.2023 Dec;16(1):1-17

• 51. [IF=9.5] Yuqin Zhang et al."Cyclodextrin-Coordinated Liposome-in-Gel for Transcutaneous Quercetin Delivery for Psoriasis Treatment."ACS Applied Materials & Interfaces.2023;XXXX(XXX):XXX-XXX

• 50. [IF=9.9] Ma Jiajia et al."Adaptable “bubble particles” prepared by green aqueous phase reshaping for completely removing odor."Nano Research.2023 Aug;:1-9

• 49. [IF=2.586] Junyu Chen et al."HGF-modified human umbilical cord mesenchymal stem cells rescue impaired ovarian reserve function in chemotherapy-induced POI rats by improving angiogenesis while decreasing apoptosis and fibrosis in the ovary."TISSUE & CELL.2023 May;:10

• 48. [2.213] Lin Li et al."Study on Quality Control of Tenofovir Disoproxil Fumarate Enantiomers by High-Performance Liquid Chromatography–Mass Spectrometry."CHROMATOGRAPHIA.2023 Feb;:1-10

• 47. [5.561] Qing Li et al."Microencapsulation with Different Starch-Based Polymers for Improving Oxidative Stability of Cold-Pressed Hickory (Carya cathayensis Sarg.) Oil."Foods.2023 Jan;12(5):953

• 46. [3.841] Congcong Wang et al."Fabrication of Hesperetin/hydroxypropyl-β-cyclodextrin Complex Nanoparticles for Enhancement of Bioactivity Using Supercritical Antisolvent Technology."JOURNAL OF MOLECULAR STRUCTURE.2023 Jan;:134947

• 45. [5.561] Hongbo Li et al."Encapsulation of Benzyl Isothiocyanate with β-Cyclodextrin Using Ultrasonication: Preparation, Characterization, and Antibacterial Assay."Foods.2022 Jan;11(22):3724

• 44. [IF=9.147] Maoyun Li et al."Development and characterization of active bilayer film incorporated with dihydromyricetin encapsulated in hydroxypropyl-β-cyclodextrin for food packaging application."FOOD HYDROCOLLOIDS. 2022 Oct;131:107834

• 43. [IF=6.953] Wen Zhu et al."Artemisinin hydroxypropyl-β-cyclodextrin inclusion complex loaded with porous starch for enhanced bioavailability."INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. 2022 Jun;211:207

• 42. [IF=4.411] Jifen Zhang et al."A Novel Solid Nanocrystals Self-Stabilized Pickering Emulsion Prepared by Spray-Drying with Hydroxypropyl-β-cyclodextrin as Carriers."Molecules. 2021 Jan;26(6):1809

• 41. [IF=4.539] Bo Zhang et al."Use of hydroxypropyl β-cyclodextrin as a dual functional component in xanthan hydrogel for sustained drug release and antibacterial activity."Colloid Surface A. 2020 Feb;587:124368

• 40. [IF=4.939] Wenqiang Su et al."Inhalation of Tetrandrine-hydroxypropyl-β-cyclodextrin Inclusion Complexes for Pulmonary Fibrosis Treatment."Mol Pharmaceut. 2020;17(5):1596–1607

• 39. [IF=6.165] Shaoping Ma et al."Deep-eutectic solvents simultaneously used as the phase-forming components and chiral selectors for enantioselective liquid-liquid extraction of tryptophan enantiomers."J Mol Liq. 2020 Dec;319:114106

• 38. [IF=1.633] Wan Hui-da et al."Enzymatic production of steviol using a commercial β-glucosidase and preparation of its inclusion complex with γ-CD."J Incl Phenom Macro. 2019 Apr;93(3):193-201

• 37. [IF=5.875] Chao Hong et al."Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: An in vitro and in vivo evaluation."Int J Pharmaceut. 2014 Dec;477:251

• 36. [IF=6.044] Yashu Yao et al."Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: Preparation, characterization, and evaluation."Carbohyd Polym. 2014 Sep;110:329

• 35. [IF=7.312] Runping Wang et al."Biphasic recognition chiral extraction of threonine enantiomers in a two-phase system formed by hydrophobic and hydrophilic deep-eutectic solvents."Sep Purif Technol. 2019 May;215:102

• 34. [IF=9.381] Qiuna Zhou et al."Preparation and characterization of inclusion complexes formed between baicalein and cyclodextrins."Carbohyd Polym. 2013 Jun;95:733

• 33. Yanping Wu, Yue Xiao, Yuxi Yue, Kai Zhong, Yinglan Zhao, Hong Gao, A deep insight into mechanism for inclusion of 2R,3R-dihydromyricetin with cyclodextrins and the effect of complexation on antioxidant and lipid-lowering activities, Food Hydrocolloids, Vol

• 32. Ma, Shaoping, et al. "Deep-eutectic solvents simultaneously used as the phase-forming components and chiral selectors for enantioselective liquid-liquid extraction of tryptophan enantiomers." Journal of Molecular Liquids 319 (2020): 114106.https://doi.org/

• 31. Wang, Runping, et al. "Biphasic recognition chiral extraction of threonine enantiomers in a two-phase system formed by hydrophobic and hydrophilic deep-eutectic solvents." Separation and Purification Technology 215 (2019): 102-107.https://doi.org/10.1016/j

• 30. Yao, Yashu, et al. "Development of a myricetin/hydroxypropyl-β-cyclodextrin inclusion complex: Preparation, characterization, and evaluation." Carbohydrate polymers 110 (2014): 329-337.https://doi.org/10.1016/j.carbpol.2014.04.006

• 29. Hong, Chao, et al. "Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation." International journal of pharmaceutics 477.1-2 (2014): 251-260.https://doi.org/10.1016/j.ijpharm

• 28. 楊擋,封亮,劉俊,趙菁,李超,朱法根,邵建國,賈曉斌,孫娥.基于物料性質(zhì)表征技術(shù)的蒲地藍(lán)消炎口服液兒童用藥順應(yīng)性改善研究[J].世界中醫(yī)藥,2020,15(15):2221-2227.

• 27. 張利竣,吳盈盈,吳瑾瑾,石森林.燈盞花素溫敏型鼻用原位凝膠的體外釋放和生物黏附性考察[J].中國現(xiàn)代應(yīng)用藥學(xué),2020,37(23):2863-2867.

• 26. 楊擋,封亮,劉俊,趙菁,李超,朱法根,邵建國,賈曉斌,孫娥.基于物料性質(zhì)表征技術(shù)的蒲地藍(lán)消炎口服液兒童用藥順應(yīng)性改善研究[J].世界中醫(yī)藥,2020,15(15):2221-2227.

• 25. 韓東旭,李天樂,苗瑞丹,王瑤,劉麗艷,于湛.七-(2,6-二甲基)-β-環(huán)糊精對木犀草素的增溶研究[J].中國現(xiàn)代應(yīng)用藥學(xué),2020,37(22):2747-2751.

• 24. 劉忠博. 基于環(huán)糊精的食品級Pickering乳液構(gòu)建[D].河南科技學(xué)院,2021.

• 23. 張波,蘇衍華,龐麗艷,陳章良,李兆樓,王鳳琴.卡拉膠/瓊脂/羥丙基-β-環(huán)糊精復(fù)合凝膠的合成及其載藥性能研究[J].濟(jì)寧醫(yī)學(xué)院學(xué)報(bào),2020,43(04):242-247.

• 22. 庫爾班江·巴拉提. 槲皮素環(huán)糊精包合物的制備工藝及溶解性研究[J]. 食品安全質(zhì)量檢測學(xué)報(bào), 2016.

• 21. 石光 邱野 高雯 等. 參紅通絡(luò)顆粒制備工藝中揮發(fā)油穩(wěn)定化方法的研究[J]. 時珍國醫(yī)國藥 2015(05):1133-1135.

• 20. 郤慶, 吳婉靜, 李國文. 楊梅素羥丙基-β-環(huán)糊精包合物的制備[J]. 藥學(xué)服務(wù)與研究, 2016, 16(003):211-215.

• 19. 趙源征, 張敏, 劉恒方,等. 黃體酮對大鼠局灶性腦缺血后血腦屏障的保護(hù)[J]. 醫(yī)藥論壇雜志, 2014, 035(009):5-7.

• 18. 鐘賽意, 劉壽春, 陳建平,等. 高良姜油-羥丙基-β-環(huán)糊精包合物的抗氧化活性及抑制亞硝胺合成作用[J]. 食品科學(xué), 2018, 39(19):127-134.

• 17. 朱士龍, 陳迪釗, 李勇,等. 青藤堿與羥丙基-β-環(huán)糊精的包合作用[J]. 精細(xì)化工, 2012(02):60-64+109.

• 16. 陸兆光, 萬琴, 孟瑾,等. 青蒿揮發(fā)油羥丙基-β-環(huán)糊精包合物的制備及其抗病毒活性分析簡[J]. 中國實(shí)驗(yàn)方劑學(xué)雜志, 2018(18):11-15.

• 15. 劉平安, 何群, 李順祥,等. 鐵皮石斛滴眼液的制備工藝研究.

• 14. 韋小翠, 楊書婷, 張焱,等. 都梁方中揮發(fā)油β-環(huán)糊精包合物的制備[J]. 中成藥, 2019, 41(04):7-12.

• 13. 樊保民, 郝華, 楊彪,等. 超分子緩蝕劑在冷凝水管線鋼表面的組裝機(jī)理[J]. 表面技術(shù), 2018, v.47(10):33-40.

• 12. 關(guān)秀鋒, 王銳, 楊婧. 蛇床子環(huán)糊精包合物接枝溫敏凝膠的制備與體外釋放[J]. 化學(xué)工程師, 2019, 033(012):63-67.

• 11. 沈新宇,徐蓉蓉,王星辰,黃罡,胡榮.薏苡素-2-羥丙基-β-環(huán)糊精包合物凍干粉的制備和表征[J].中國新藥雜志,2019,28(16):2040-2048.

• 10. 李進(jìn)霞, 于肯明, 張慧芝,等. 芹菜素-環(huán)糊精包合物在溶液中的制備,表征及抗氧化性[J]. 山西大同大學(xué)學(xué)報(bào)(自然科學(xué)版), 2015, 000(006):40-43.

• 9. 趙厚菲, 呼芷晴, 徐永霞,等. 肉桂醛-羥丙基-β-環(huán)糊精包合物的噴霧干燥法制備及表征[J]. 包裝與食品機(jī)械, 2020, 038(001):25-29.

• 8. 姜慧明,楊紅.羥丙基β-環(huán)糊精對多菌靈的熒光增敏效應(yīng)[J].沈陽農(nóng)業(yè)大學(xué)學(xué)報(bào),2013,44(06):820-822.

• 7. 段友構(gòu), 朱士龍, 張浚生,等. 環(huán)糊精對青蒿素的包合工藝研究[J]. 食品科學(xué), 2013, 34(008):89-93.

• 6. 徐磊, 蔣劍平, 金銘,等. 溫莪術(shù)油羥丙基-β-環(huán)糊精包合物的制備與表征[J]. 中華中醫(yī)藥雜志, 2015(4):1043-1046.

• 5. 王銳, 李建月, 楊婧. 川芎提取物接枝型鼻用溫敏凝膠制備及藥效學(xué)研究[J]. 上海中醫(yī)藥雜志, 2019, v.53;No.593(06):92-97.

• 4. 張曉沖, 廖啟元, 翟光喜. 姜黃素包合物胃內(nèi)漂浮微球的研制[J]. 現(xiàn)代中藥研究與實(shí)踐, 2014, 028(001):56-59.

• 3. 王曉娟, 王魁麟, 陸兆光,等. 姜黃揮發(fā)油羥丙基-β-環(huán)糊精包合物的制備、穩(wěn)定性及其抗真菌活性[J]. 中國新藥與臨床雜志, 2019, 038(007):433-439.

• 2. 周慧 鄭一敏 胥秀英. 雙氫青蒿素-羥丙基-β-環(huán)糊精包合物的制備工藝研究[J]. 中國當(dāng)代醫(yī)藥 2016 23(008):9-11.

• 1. 姜慧明 楊紅. β-環(huán)糊精對多菌靈的熒光增敏效應(yīng)研究[J]. 大連民族大學(xué)學(xué)報(bào) 2014 16(1):5-9.

輸入產(chǎn)品批號：

本計(jì)算器可幫助您計(jì)算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系，公式為：

質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

• pg ng μg mg g kg =
  fM pM nM μM mM M *
  nL μL mL L *